Involvement of cell cycle regulatory proteins and MAP kinase signaling pathway in growth inhibition and cell cycle arrest by a selective cyclooxygenase 2 inhibitor, etodolac, in human hepatocellular carcinoma cell lines

Search this Article

Author(s)

    • CHENG Jidong
    • Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine
    • IMANISHI Hiroyasu
    • Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine
    • LIU Weidong
    • Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine
    • NAKAMURA Hideji
    • Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine
    • MORISAKI Takayuki
    • Department of Bioscience, National Cardiovascular Center Research Institute
    • HIGASHINO Kazuya
    • Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine
    • HADA Toshikazu
    • Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine

Journal

  • Cancer Sci.

    Cancer Sci. 95(8), 666-673, 2004-08-10

References:  40

Cited by:  5

Codes

  • NII Article ID (NAID)
    10013570445
  • NII NACSIS-CAT ID (NCID)
    AA11808050
  • Text Lang
    ENG
  • Article Type
    Journal Article
  • ISSN
    13479032
  • Data Source
    CJP  CJPref 
Page Top